Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

18 June 2002

Effects of immunomodulators on acute Trypanosoma Cruzi infection in mice.

Walter T Hughes, Helieh S Oz, Elaine K Thomas, Craig J McClain

Med Sci Monit 2002; 8(6): BR208-211 :: ID: 420822


BACKGROUND: Patients who recover from acute trypanosomiasis may succumbto chronic Chagas' disease later in life due to age related immunosuppression, immune system disorderssuch as AIDS, or during periods of immunosuppressive therapy for organ transplantation. In this study,effects of immunomodulators with diverse properties were examined on the course of an acute and lethalTrypanosoma cruzi infection.MATERIAL/METHODS: ICR (Swiss) mice inoculated with Tulahuen (lethal) strainof T. cruzi were treated with 6 different immunomodulators and the course of infection was studied.RESULTS:Tacrolimus (FK-506) and dexamethasone increased parasitemia in mice when compared to infected untreatedanimals. Mycophenolate mofetil (RS-61443) and recombinant interleukin-15 (IL-15) treatment decreasedthe number of parasites but had no effect on animal survival. In contrast, compound L-685-818 (tacrolimusanalog) and CD40 ligand (CD40L), provided protection against lethal infection. Mice that survived initialinfection were all protected against reinfection.CONCLUSIONS: This study demonstrates the dangers ofimmunosuppression with tacrolimus and dexamethasone in T. cruzi infected subjects. While mycophenolatedid not exacerbate the infection, our data suggest potential therapeutic applications for L-685-818 andCD40 ligand in trypanosomiasis.

Keywords: Adjuvants, Immunologic, CD40 Ligand, Dexamethasone, Immunosuppressive Agents, Interleukin-15, Mice, Inbred ICR, Mycophenolic Acid, Research Support, Non-U.S. Gov, Research Support, U.S. Gov, Research Support, U.S. Gov, Tacrolimus, Trypanosoma cruzi, Trypanosomiasis

Add Comment 0 Comments

498 2


01 May 2023 : Editorial  

Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor Therapy

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.940911

Med Sci Monit 2023; 29:e940911


In Press

31 May 2023 : Review article  

Prevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.939919  

30 May 2023 : Clinical Research  

A Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...

Med Sci Monit In Press; DOI: 10.12659/MSM.940409  

30 May 2023 : Review article  

A Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...

Med Sci Monit In Press; DOI: 10.12659/MSM.940550  

30 May 2023 : Database Analysis  

The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in Poland

Med Sci Monit In Press; DOI: 10.12659/MSM.940904  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788


30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750